RXRX

Short interest Short interest 32.8% of float

6d ago

News Nvidia Has Invested in These 6 Companies. Should You Follow Suit?

14d ago

News Why Recursion Pharmaceuticals Stock Tanked on Tuesday

14d ago

News 3 AI Stocks Partnered With Nvidia With Massive Growth Opportunities

14d ago

News Here's Why Shares in Recursion Pharmaceuticals Surged Today

14d ago

News Why Recursion Pharmaceuticals Stock Plummeted 24% This Week

14d ago

News Why Biohaven Stock Plummeted by More Than 15% Today

14d ago

News Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

14d ago

News Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

14d ago

News Why Recursion Pharmaceuticals Stock Is Skyrocketing Today

14d ago

News These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?

14d ago

News Why Recursion Pharmaceuticals Stock Is Soaring Today

14d ago

News Is Recursion Pharmaceuticals a Millionaire-Maker Stock?

14d ago

News Cathie Wood Is Betting on This AI Stock: Is It a Buy?

14d ago

News The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.

14d ago

News Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks

14d ago

News Cathie Wood's ARK trades Incyte, Recursion stock, buys Blade Air Mobility - Investing.com Canada

14d ago

News Recursion Pharmaceuticals director sells $83.7k in stock - Investing.com

14d ago

News Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor

14d ago

News Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?

14d ago

News Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing

14d ago

News Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock

14d ago

Insider trade Sale by Christopher Gibson

24d ago

Insider trade Sale by Blake Borgeson

25d ago

News Recursion outlines runway into early 2028 while maintaining 2026 cash operating expenses under $390M

26d ago